BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9098257)

  • 1. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
    Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
    Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical interventions for traumatic hyphema.
    Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD005431. PubMed ID: 30640411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema.
    Karkhaneh R; Naeeni M; Chams H; Abdollahi M; Mansouri MR
    Eur J Ophthalmol; 2003; 13(1):57-61. PubMed ID: 12635675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical interventions for traumatic hyphema.
    Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
    Cochrane Database Syst Rev; 2013 Dec; 12(12):CD005431. PubMed ID: 24302299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical interventions for traumatic hyphema.
    Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD005431. PubMed ID: 21249670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
    Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
    Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Williams PB; Gray MK; Crouch ER; Chames M
    Arch Ophthalmol; 1997 Sep; 115(9):1106-12. PubMed ID: 9298049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of risk for secondary hemorrhage in traumatic hyphema.
    Rahmani B; Jahadi HR; Rajaeefard A
    Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traumatic hyphema: outcomes of outpatient management.
    Shiuey Y; Lucarelli MJ
    Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid.
    Kraft SP; Christianson MD; Crawford JS; Wagman RD; Antoszyk JH
    Ophthalmology; 1987 Oct; 94(10):1232-7. PubMed ID: 3317180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema.
    McGetrick JJ; Jampol LM; Goldberg MF; Frenkel M; Fiscella RG
    Arch Ophthalmol; 1983 Jul; 101(7):1031-3. PubMed ID: 6870623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of traumatic hyphema with topical epsilon-aminocaproic acid.
    Goldberg MF
    Arch Ophthalmol; 1997 Sep; 115(9):1189-90. PubMed ID: 9298063
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
    Rahmani B; Jahadi HR
    Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid in the treatment of pediatric traumatic hyphema.
    Albiani DA; Hodge WG; Pan YI; Urton TE; Clarke WN
    Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema. A randomized clinical trial.
    Farber MD; Fiscella R; Goldberg MF
    Ophthalmology; 1991 Mar; 98(3):279-86. PubMed ID: 2023746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traumatic hyphema and patient outcomes--an oversight.
    Shiuey Y; Lucarelli MJ
    Ophthalmology; 1998 Dec; 105(12):2165. PubMed ID: 9855140
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid.
    Beiran I; Talmon T; Miller B
    Isr Med Assoc J; 2002 Nov; 4(11):1009-10. PubMed ID: 12489492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent bleeding following traumatic hyphema due to mild hemophilia B (Christmas disease).
    Wilker SC; Singh A; Ellis FJ
    J AAPOS; 2007 Dec; 11(6):622-3. PubMed ID: 17720569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphemas.
    Palmer DJ; Goldberg MF; Frenkel M; Fiscella R; Anderson RJ
    Ophthalmology; 1986 Jan; 93(1):102-8. PubMed ID: 3951807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient management of traumatic hyphemas in children.
    Coats DK; Viestenz A; Paysse EA; Plager DA
    Binocul Vis Strabismus Q; 2000; 15(2):169-74. PubMed ID: 10893460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.